Berlin, Germany

Matthias Burger

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Epigenomics Ag. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Burger. Retrieved from https://idiyas.com/inventor/matthias-burger-s8igwoqd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Matthias Burger: Innovator in Colon Cell Proliferative Disorder Analysis

Introduction

Matthias Burger is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the analysis of colon cell proliferative disorders. With a total of 2 patents, his work has the potential to impact the diagnosis and treatment of these conditions.

Latest Patents

Matthias Burger's latest patents include innovative methods and nucleic acids for the analysis of colon cell proliferative disorders. The first patent provides methods and nucleic acids for detecting, differentiating, or distinguishing between colon cell proliferative disorders by analyzing genes such as Versican, TPEF, H-Cadherin, Calcitonin, and EYA4. This invention also includes novel nucleic acid sequences that are useful for specific analysis of these genes, along with methods, assays, and kits. The second patent focuses on the analysis of colorectal cell proliferative disorders, offering methods and nucleic acids for detecting and differentiating these disorders through the analysis of the gene EYA4 and its regulatory sequences. This invention also provides novel nucleic acid sequences and associated methods, assays, and kits.

Career Highlights

Matthias Burger is currently associated with Epigenomics AG, a company that specializes in molecular diagnostics. His work at Epigenomics AG has allowed him to further develop his innovative ideas and contribute to advancements in the field of medical diagnostics.

Collaborations

Matthias has collaborated with notable colleagues such as Peter Adorjan and Sabine Maier. These collaborations have enriched his research and have been instrumental in the development of his patented technologies.

Conclusion

Matthias Burger is a key figure in the field of colon cell proliferative disorder analysis, with his patents paving the way for improved diagnostic methods. His contributions are vital for advancing medical science and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…